Decibel Cannabis Company Insider Trading
TSX-V DB
8
All Trades
2
Significant
1
Notable
2
Clusters
5
Repeat
Healthcare
Sector
Drug Manufacturers
Industry
$72.1M
Market Cap
0.09 – 0.14
52 Week Range
552K
Avg. Volume
| Company | Insider | Title | Tr. Date | Fi. Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|---|
| Decibel Cannabis Company | Dym, Shawn | Director | 13-Jul-26 | 13-Jul-26 | 12,502,500 | MN RP | ||||
| Decibel Cannabis Company | Dym, Shawn | Director | 08-Jul-26 | 09-Jul-26 | 12,105,000 | MN RP | ||||
| Decibel Cannabis Company | Dym, Shawn | Director | 07-Jul-26 | 09-Jul-26 | 11,855,000 | MN RP | ||||
| Decibel Cannabis Company | Dym, Shawn | Director | 06-Jul-26 | 09-Jul-26 | 11,665,000 | MN RP | ||||
| Decibel Cannabis Company | Dym, Shawn | Director | 02-Jul-26 | 03-Jul-26 | 11,605,000 | MN RP | ||||
| Decibel Cannabis Company | Ripshtein, Jakob | Director | 12-Jun-25 | 13-Jun-25 | 1,194,333 | NT CL | ||||
| Decibel Cannabis Company | Sze, Benjamin | CEO | 11-Jun-25 | 13-Jun-25 | 7,133,333 | SI CL | ||||
| Decibel Cannabis Company | Dym, Shawn | Director | 05-Jun-25 | 06-Jun-25 | 10,159,500 | SI |
Decibel Cannabis Company (DB): Insider trading △ Insider buy
Volume (thousands)
Related Companies to Explore
Company Info
Decibel Cannabis Company is a Canadian integrated cannabis company operating in the cultivation, processing, and sale of cannabis products. The company produces cannabis flower as well as a range of derivative products, including vapes, cannabis-infused pre-rolls, pre-rolls, edibles, and other value-added products. Its business activities include business-to-business cannabis product sales in Saskatchewan and Alberta, as well as direct e-commerce sales to end-user customers in Saskatchewan. The company markets its products under four brands: Qwest, Vox, Blendcraft, and General Admission. Decibel Cannabis Company is headquartered in Calgary, Canada, and operates within the healthcare sector, specifically in the specialty and generic drug manufacturing industry.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.
